December 13, 2024 21:15 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess

India remains engaged with US for vaccines, Joe Biden assures to support COVAX

Jun 04, 2021, at 03:59 am

New Delhi/IBNS: The Centre on Thursday informed that the government has been making all efforts to augment the availability of vaccines in India, whether through enhanced production in the country or through supply from abroad.

Pfizer offers 5 cr Covid19 vaccine doses to India with conditions as External Affairs Minister S Jaishankar tours US

May 26, 2021, at 05:44 am

New Delhi/IBNS: Pfizer has offered 5 crore Covid-19 vaccine doses to India albeit with pre-conditions as the country ramps up production amid a raging pandemic.

Pfizer, Moderna won't sell vaccines to states, will deal with Centre: Arvind Kejriwal

May 24, 2021, at 07:26 pm

New Delhi/IBNS: Delhi Chief Minister Arvind Kejriwal on Monday said his government's approach to US pharmaceutical giants, Pfizer and Modern, for anti-COVID-19 vaccine shots went unsuccessful as they would only deal with the Centre and not any state.

Indian govt, Pfizer hit deadlock over issue of legal protection on vaccine side effects: Report

May 22, 2021, at 05:03 am

New Delhi/IBNS: US drug major Pfizer's coronavirus vaccine is facing hurdles in entering the Indian market over demand for legal protection from any adverse effects that may follow after the use of its jabs, a Reuters report said, citing sources.